Polar Asset Management Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Polar Asset Management Partners’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-266,960	Closed	-$6.16M	–	1363
2020 Q4	$6.16M	Buy	+266,960	New	+$3.38M	0.07%	257

Polar Asset Management Partners's PRVL Position: Q1 2021 in Review

Polar Asset Management Partners sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 266,960 shares — an estimated $6.16M sold.

Polar Asset Management Partners first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $6.16M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Polar Asset Management Partners reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Polar Asset Management Partners sold 266,960 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $6.16M.
Polar Asset Management Partners first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Polar Asset Management Partners's Prevail Therapeutics Inc. Common Stock position peaked at $6.16M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Polar Asset Management Partners's 13F filing for Q1 2021, filed 17 May 2021.